跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GEMCITABINE EUGIA gemcitabine (as hydrochloride) 200 mg/5 mL concentrated solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
GEMCITABINE EUGIA gemcitabine (as hydrochloride) 200 mg/5 mL concentrated solution for injection vial
Approved
STANDARD
GEMCITABINE EUGIA gemcitabine (as hydrochloride) 200 mg/5 mL concentrated solution for injection vial
Eugia Pharma (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Feb 12, 2026
Approval ID
5e0841fad8357069
Company
Eugia Pharma (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
5e0841fad8357069
Product Name
GEMCITABINE EUGIA gemcitabine (as hydrochloride) 200 mg/5 mL concentrated solution for injection vial
Artg Id
471173
Artg Name
GEMCITABINE EUGIA gemcitabine (as hydrochloride) 200 mg/5 mL concentrated solution for injection vial
Sponsor
Eugia Pharma (Australia) Pty Ltd
Company Detail Path
/organization/eugia-pharma-australia-pty-ltd
Artg Date
2026-02-04
Registration Type
Medicine
Therapeutic Good Type
Medicines
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Feb 12, 2026
Approval ID
5e0841fad8357069
Type
Standard
Back to TGA Approvals